[{"Assets_0_Q2_USD":"10203000000.0","CIK":"1596783","CommonStockSharesIssued_0_Q2_shares":"171032640.0","CommonStockSharesOutstanding_0_Q2_shares":"171032640.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"0.53","EarningsPerShareBasic_2_Q2_USD":"1.02","EarningsPerShareDiluted_1_Q2_USD":"0.52","EarningsPerShareDiluted_2_Q2_USD":"1.01","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"17076283108.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"232000000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":"93000000.0","NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":"177000000.0","NetIncomeLoss_1_Q2_USD":"97000000.0","NetIncomeLoss_2_Q2_USD":"190000000.0","OfficialName":"Catalent Inc. Common Stock","ProfitLoss_2_Q2_USD":"190000000.0","RevenuesConverted_1_Q2_USD":"1217000000.0","RevenuesConverted_2_Q2_USD":"2242000000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":"4481000000.0","StockholdersEquity_0_Q2_USD":"4481000000.0","Ticker":"CTLT","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"177000000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"175000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"175000000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"173000000.0","filed":"20220201","footnote":null,"form":"10-Q","fp":"Q2","fy":"2022.0","name":"CATALENT, INC.","period":"20211231","qtrs":"0","uom":"USD"}]